Front. Physiol. Frontiers in Physiology Front. Physiol. 1664-042X Frontiers Media S.A. 10.3389/fphys.2014.00291 Physiology Review Article Cardiac magnetic resonance and computed tomography angiography for clinical imaging of stable coronary artery disease. Diagnostic classification and risk stratification Korosoglou Grigorios * Giusca Sorin Gitsioudis Gitsios Erbel Christian Katus Hugo A. Department of Cardiology, University of Heidelberg Heidelberg, Germany

Edited by: Gerald A. Meininger, University of Missouri, USA

Reviewed by: Jaw-Wen Chen, National Yang-Ming University School of Medicine, Taiwan; Antonio Francesco Corno, University Sains Malaysia, Malaysia

*Correspondence: Grigorios Korosoglou, Department of Cardiology, University of Heidelberg, Im Neuenheimer Feld 410, Heidelberg, 69120, Germany e-mail: gkorosoglou@hotmail.com

This article was submitted to Vascular Physiology, a section of the journal Frontiers in Physiology.

 06 08 2014 2014 5 291 10 05 2014 18 07 2014 Copyright © 2014 Korosoglou, Giusca, Gitsioudis, Erbel and Katus. 2014

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Despite advances in the pharmacologic and interventional treatment of coronary artery disease (CAD), atherosclerosis remains the leading cause of death in Western societies. X-ray coronary angiography has been the modality of choice for diagnosing the presence and extent of CAD. However, this technique is invasive and provides limited information on the composition of atherosclerotic plaque. Coronary computed tomography angiography (CCTA) and cardiac magnetic resonance (CMR) have emerged as promising non-invasive techniques for the clinical imaging of CAD. Hereby, CCTA allows for visualization of coronary calcification, lumen narrowing and atherosclerotic plaque composition. In this regard, data from the CONFIRM Registry recently demonstrated that both atherosclerotic plaque burden and lumen narrowing exhibit incremental value for the prediction of future cardiac events. However, due to technical limitations with CCTA, resulting in false positive or negative results in the presence of severe calcification or motion artifacts, this technique cannot entirely replace invasive angiography at the present time. CMR on the other hand, provides accurate assessment of the myocardial function due to its high spatial and temporal resolution and intrinsic blood-to-tissue contrast. Hereby, regional wall motion and perfusion abnormalities, during dobutamine or vasodilator stress, precede the development of ST-segment depression and anginal symptoms enabling the detection of functionally significant CAD. While CT generally offers better spatial resolution, the versatility of CMR can provide information on myocardial function, perfusion, and viability, all without ionizing radiation for the patients. Technical developments with these 2 non-invasive imaging tools and their current implementation in the clinical imaging of CAD will be presented and discussed herein.

 coronary artery disease atherosclerotic plaque coronary computed tomography cardiac magnetic resonance risk stratification Introduction

Despite major advances in the treatment of coronary artery disease (CAD), it still remains one of the leading causes of death in Western societies (Murray and Lopez, 1997; Myerburg et al., 1997; Naghavi et al., 2003). The role of inflammation and the key role of plaque macrophages in all stages of atherosclerosis is widely appreciated (Libby et al., 2002; Swirski et al., 2006). Such inflamed atherosclerotic plaques typically exhibit a lipid-rich pool, overexpression of collagenases and metalloptroteinases and a thin fibrotic cap (van Rugge et al., 1993). The secretion of proteolytic enzymes by lesional macrophages can cause destabilization of cap tissues, resulting in plaque rupture (Figure 1).

The role of inflammation in atherosclerotic disease. Macrophages engulfing oxidized LDL transform to foam cells (A). The secretion of metalloptroteinases subsequently causes destabilization of cap tissues, resulting in plaque rupture (B).

X-ray coronary angiography is the current clinical gold-standard technique for the detection of CAD. Coronary angiography provides an accurate measure of stenosis. However, this technique is invasive and almost entirely relies on anatomic structure of the vascular lumen (Vallabhajosula and Fuster, 1997), providing limited information on the composition of the arterial wall (Fuster et al., 1992; Topol and Nissen, 1995). Furthermore, the phenomenon of vascular remodeling decreases the sensitivity of coronary angiography to detect the true atherosclerotic plaque burden. Revascularization techniques of coronary artery bypass surgery (CABG) and percutaneous coronary interventions (PCI) are currently guided by findings provided by X-ray angiography, and therefore target high-grade coronary lesions. However, acute coronary syndromes most commonly result from the rupture of plaques that are angiographically modest in severity (non-critical stenoses) (Fuster et al., 1992; Korosoglou et al., 2008a). Therefore, the currently used revascularization strategies may do little to prevent future coronary events (Libby, 2001; Boden et al., 2007).

 Cardiac magnetic resonance imaging

Cardiac Magnetic Resonance (CMR) can provide non-invasive imaging with sub-millimeter spatial resolution and high blood-to-tissue contrast (Toussaint et al., 1996). Due to its non-invasive nature, high intrinsic contrast and the absence of radiation exposure for the patients, CMR is to date the preferred technique for the assessment of cardiac morphology and function. In this regard, the versatility of CMR can provide assessment of myocardial function, perfusion, viability and if required cardiac metabolism within a single “one stop shop” non-invasive examination. Furthermore, its tomographic nature provides excellent comparability between perfusion and function of corresponding myocardial segments and high reproducibility of the acquired results.

Diagnosis of coronary artery disease

Modern CMR 1.5 & 3.0 Tesla clinical scanners provide high temporal (~40ms) and spatial (<1.0*1.0 mm in plane) resolution for the assessment of cardiac function. The latter is almost 10-fold higher compared to competing nuclear scintigraphy techniques. Although earlier CMR studies had limitations, such as poor slice coverage and low temporal resolution, limiting the detection of CAD, subsequent data demonstrated that CMR compares favorably to SPECT for the detection of myocardial ischemia (Schwitter et al., 2001, 2012, 2013; Wagner et al., 2003). In a recent prospective, real-world clinical trial, which included 752 consecutive patients, CMR exhibited significantly higher diagnostic accuracy compared to SPECT for CAD detection (Greenwood et al., 2012).

Detection of CAD using CMR is mainly based on the evaluation of the functional significance of coronary artery stenosis during pharmacologic stress testing with either adenosine or dipyridamole, i.e., coronary vasodilators, or dobutamine, which is a synthetic ß-adrenergic stimulator. Using stress CMR, inducible myocardial ischemia can be detected in form of inducible wall motion abnormalities during dobutamine stress or in form of perfusion deficits during vasodilator stress, which both precede the development of ST-segment depression and anginal symptoms in the ischemic cascade (Figure 2) and have been reported to accurately detect functionally significant CAD (Pennell et al., 1990, 1992; van Rugge et al., 1993, 1994; Hundley et al., 1999; Nagel et al., 1999, 2003; Schwitter et al., 2001; Schalla et al., 2002; Doyle et al., 2003; Ishida et al., 2003; Rerkpattanapipat et al., 2003; Giang et al., 2004; Kawase et al., 2004; Paetsch et al., 2004, 2006; Plein et al., 2004, 2005; Takase et al., 2004; Sakuma et al., 2005; Cury et al., 2006; Jahnke et al., 2006; Klem et al., 2006; Pilz et al., 2006; reviewed in Nandalur et al., 2007). Flow charts for these 2 forms of pharmacologic stress CMR with corresponding time spent are illustrated in Figures 3A,B for dobutamine and adenosine stress CMR, respectively. Due to its tomographic nature, CMR allows for sequential acquisition of identical slices (each segment at baseline serves as its own control during peak stress), providing the reproducible and accurate assessment of wall motion and strain response during dobutamine stress testing. Similarly, myocardial perfusion can be assessed in identical slices during baseline and pharmacologic hyperemia.

Temporal sequence of events in terms of metabolic & myocardial dysfunction during ischemia.

Flow chart illustrating the time course of adenosine perfusion and dobutamine stress CMR examinations (A,B).

In a meta-analysis including 14 dobutamine and 24 adenosine stress CMR studies with 754 and 1516 patients, respectively sensitivities and specificities of 83% (95% confidence interval of 79–88%), 86% (95% confidence interval of 81–91%) and of 91% (95% confidence interval of 88–94%) and 81% (95% confidence interval of 77–85%), respectively were reported (Tables 1, 2). Especially after exclusion of studies utilizing dipyridamole as a stressor, the assessment of inducible wall motion abnormalities exhibited an improved sensitivity of 85% (95% confidence interval of 82–90%) without a loss in terms of specificity. Furthermore, in a direct comparison between adenosine and dobutamine stress CMR in 79 consecutive patients with suspected or known CAD, the analysis of inducible wall motion abnormalities during dobutamine CMR offered the best trade-off between sensitivity and specificity (Paetsch et al., 2004). In this regard, the latter provided sensitivity of 89% and specificity of 80% for the identification of patients with significant CAD.

Studies performed with dobutamine stress CMR for the detection of CAD by inducible wall motion abnormalities.

Study Stressor(s) Number of patients MR-scanner Definition of relevant stenosis (%) Sensitivity (%) with 95%CI Specificity (%) with 95%CI
Hundley et al., 1999 Dobutamine/Atropin 41 GE 1.5T >50 83 (86–93) 83 (36–100)
Jahnke et al., 2006 Dobutamine 40 Philips 1.5T ≥50 83 (51–97) 89 (71–97)
Nagel et al., 1999 Dobutamine 172 Philips 1.5T ≥50 86 (78–92) 86 (75–93)
Paetsch et al., 2004 Dobutamine/Atropin 79 Philips 1.5T >50 89 (77–96) 81 (61–93)
Paetsch et al., 2006 Dobutamine 150 Philips 1.5T ≥50 78 (67–87) 88 (78–94)
Pennell et al., 1992 Dobutamine 25 Picker 0.5T ≥50 91 (71–99) 100 (29–100)
Rerkpattanapipat et al., 2003 Exercise 27 GE 1.5T >70 79 (49–95) 85 (55–98)
Schalla et al., 2002 Dobutamine 22 Philips 1.5T >75 81 (54–96) 83 (36–100)
van Rugge et al., 1993 Dobutamine 45 Philips 1.5T >50 81 (65–92) 100 (63–100)
van Rugge et al., 1994 Dobutamine 39 Philips 1.5T ≥50 91 (76–98) 83 (36–100)
Pooled data Dobutamine ± Atropin 680 ≥50–75 85 (82–90) 86 (81–91)

Vasodilator stress perfusion CMR for the detection of CAD.

Study Stressor(s) Number of patients MR-scanner Definition of relevant stenosis (%) Sensitivity (%) with 95%CI Specificity (%) with 95%CI
Cury et al., 2006 Dipyridamole 47 GE 1.5T ≥70 87 (74–94) 89 (80–95)
Doyle et al., 2003 Dipyridamole 199 Philips 1.5T ≥70 58 (37–77) 78 (71–84)
Giang et al., 2004 Adenosine 44 GE 1.5T ≥50 93 (77–99) 75 (48–92)
Pennell et al., 1990 Dipyridamole 40 Picker 0.5T Not specified 62 (45–77) 100 (3–100)
Ishida et al., 2003 Dipyridamole 104 GE 1.5T ≥70 90 (81–95) 85 (67–94)
Kawase et al., 2004 Nicorandil 50 Philips 1.5T >70 94 (80–99) 94 (71–100)
Klem et al., 2006 Adenosine 95 Siemens 1.5T ≥70 89 (75–97) 87 (76–95)
Nagel et al., 2003 Adenosine 90 Philips 1.5T ≥75 88 (75–96) 90 (77–97)
Pilz et al., 2006 Adenosine 176 GE 1.5T >70 96 (91–99) 83 (71–91)
Plein et al., 2004 Adenosine 71 Philips 1.5T ≥70 96 (88–100) 83 (52–98)
Plein et al., 2005 Adenosine 92 Philips 1.5T >70 88 (77–95) 82 (52–90)
Sakuma et al., 2005 Dipyridamole 40 Siemens 1.5T >70 81 (58–95) 68 (43–87)
Schwitter et al., 2001 Dipyridamole 48 GE 1.5T ≥50 87 (71–95) 85 (35–93)
Takase et al., 2004 Dipyridamole 102 GE 1.5T >50 93 (85–98) 85 (65–96)
Paetsch et al., 2004 Adenosine 79 Philips 1.5T >50 91 (79–97) 62 (41–80)
Pooled data Vasodilator stress 1237 91 (88–94) 81 (77–85)

An example of a patient with inducible wall motion abnormality of the anterior-septal apical wall during peak dobutamine stress CMR is illustrated in Figures 4A–D. Corresponding angiographic images, demonstrating collateralized occlusion of the LAD can be appreciated in Figures 4E,F.

Patient undergoing DCMR for suspected progression of CAD after PCI and stent placement in the LAD two years ago. During peak DCMR inducible wall motion abnormality of the LV-apex and anterior-septal wall can be observed (normal wall motion at baseline in A,B and inducible akinesia during peak stress (red arrows in C,D). Subsequent coronary angiography demonstrates collateralized occlusion of the LAD (red arrows in E,F).

Despite the high diagnostic value and reproducibility of stress CMR (Paetsch et al., 2006), and its in the meanwhile wide acceptance among cardiologists in the clinical practice, the assessment of cine images relies on visual interpretation of regional wall motion, which is subjective and depends on the experience of the readers. Recently, Strain-Encoded-MRI (SENC) has been proposed for the objective color coded evaluation of regional myocardial strain. Using SENC, myocardial deformation can be assessed visually using a color coded scale, whereas strain and strain rate can be quantified in circumferential and longitudinal direction. The ability of SENC to quantify myocardial strain has been validated in experimental and in clinical settings (Kraitchman et al., 2003; Pan et al., 2006; Korosoglou et al., 2008b, 2009a,b,c, 2010a, 2011a; Youssef et al., 2008; Neizel et al., 2009) and this technique favorably compares over more conventional CMR tagging sequences in terms of temporal resolution, total scan duration and time-spent required for the post-processing of the acquired data. In a direct comparison of conventional tagging to SENC, the latter demonstrated non-inferior overall accuracy for the detection of functional significant CAD. Furthermore, studying 101 consecutive patients, we previously demonstrated the ability of the direct color coded visualization of strain on SENC images to enhance the sensitivity of dobutamine stress CMR (86 vs. 98%, p < 0.05) for the detection of obstructive CAD (Korosoglou et al., 2009b). Interestingly, quantitative myocardial strain rate already decreased with moderate 40–60% coronary artery stenosis, before relevant reduction of myocardial strain and the occurrence of evident inducible wall abnormalities by conventional cine imaging. In addition, SENC enabled the detection of functional significant CAD already during intermediate dobutamine stress CMR (at 20 μg/kg of body weight), which may provide improved patient safety within a lower time spent (Korosoglou et al., 2010a).

An example of a patient with an increasing strain abnormality in the anterior-septal wall during dobutamine stress (Figures 5A,B; red arrows in Figure 5B) can be appreciated in Figure 5. The presence of a high grade left anterior descending (LAD) stenosis was confirmed by coronary angiography (red and blue arrows depicting high grade lesions in the proximal and mid part of the LAD, respectively in Figure 5C).

Patient with an increasing strain abnormality in the anterior-septal wall during dobutamine stress CMR (A,B; red arrows in B). A high grade left anterior descending (LAD) stenosis was observed by coronary angiography (red and blue arrows depicting high grade lesions in the proximal and mid part of the artery, respectively in C).

Similar to the assessment of wall motion abnormalities, most CMR centers perform visual analysis of perfusion scans for the diagnosis of inducible myocardial ischemia in the clinical routine. In this regard, the transmural extent of a perfusion deficit is determined from dynamic images showing the maximum extent of regional hypoenhancement. Hereby, increase in regional hypoenhancement during adenosine or dypiridamole stress (≥25% increase in hypoenhancement transmurality compared to baseline scans) in at least one myocardial segment, which persists for ≥5 consecutive image frames, is considered as indicative of inducible ischemia (Korosoglou et al., 2010b). Several studies also demonstrated the value of myocardial perfusion assessment during high dose dobutamine stress CMR for the detection of CAD, particularly in patients with left ventricular hypertrophy and concentric remodeling (Gebker et al., 2008, 2010). Recently, fully quantitative stress perfusion CMR was shown to exhibit higher precision for the detection of obstructive CAD (≥70% stenosis) compared to semi-quantitative and visual assessment (Mordini et al., 2014). Multi-center studies are now warranted, in order to investigate the potential of such fully quantitative stress perfusion algorithms for the diagnostic work-up of patients with suspected or known CAD in the clinical routine.

Recent studies have also demonstrated the cost-effectiveness of CMR in the clinical routine. Thus, an economic evaluation of the CE-MARC study, which showed that CMR has superior diagnostic accuracy to SPECT (Greenwood et al., 2012, 2014), demonstrated that CMR is also a cost-effective strategy in patients with suspected CAD (Walker et al., 2013). In addition, stress CMR was shown to represent an effective and cost-reducing strategy in the diagnostic work-up of patients with acute chest pain and intermediate likelihood for evolving acute coronary syndromes (Miller et al., 2011; Hall et al., 2012). Currently, the early implementation of CCTA and CMR in the diagnostic process of patients with suspected non-ST-elevation myocardial infarction and its influence in terms of diagnostic classification, outcomes, and cost-effectiveness is investigated in the CARMENTA trial (Smulders et al., 2013).

 Assessment of clinical outcomes

Estimating the risk for subsequent cardiac events is of paramount importance in patients with known or suspected CAD, because an invasive therapy is warranted for patients with myocardial ischemia who are at high-risk for future events according to current guidelines (Montalescot et al., 2013). Several studies have previously demonstrated the usefulness of both vasodilator perfusion and dobutamine stress CMR for the estimation of clinical outcomes in patients with CAD (Ingkanisorn et al., 2006; Bodi et al., 2007; Jahnke et al., 2007, 2012; Pilz et al., 2008; Doesch et al., 2009; Lerakis et al., 2009; Steel et al., 2009; Vogel-Claussen et al., 2009; Charoenpanichkit et al., 2010; Korosoglou et al., 2010b; Bingham and Hachamovitch, 2011; Coelho-Filho et al., 2011; Gebker et al., 2011, 2012; Kelle et al., 2011; Krittayaphong et al., 2011; Lo et al., 2011; Lubbers et al., 2012; Bertaso et al., 2013; Buckert et al., 2013, reviewed in Lipinski et al., 2013). A recent meta-analysis systematically analyzed these data, including 14 vasodilator, 4 dobutamine studies and 1 study using both adenosine and dobutamine in a total of over 11,500 patients and with a mean follow-up duration of over 2.5 years (Lipinski et al., 2013). In this large meta-analysis, patients with inducible ischemia by stress CMR exhibited a markedly higher risk for future cardiac events, including myocardial infarction (odds ratio = 7.7) and cardiovascular death (odds ratio = 7.0) compared to those without inducible wall motion or perfusion abnormalities during CMR stress testing. The number of patients, mean follow-up duration, proportion of patients with known CAD and positive stress test results, as well as the odds ratio for future cardiac events in patients with inducible wall motion abnormalities or perfusion defects are illustrated for each of these studies in Table 3.

Studies demonstrating the ability of dobutamine and vasodilator stress CMR for the assessment of clinical outcomes.

Study Mean follow-up (years) Number of patients Known CAD (%) Proportion of patients with positive stress (%) Odds ratio in patients with positive CMR
DOBUTAMINE STRESS CMR
Charoenpanichkit et al., 2010 6.0 353 Not reported 31 3.1
Gebker et al., 2011 2.1 1167 48 40 11.3
Jahnke et al., 2007 2.3 513 54 41 4.7
Kelle et al., 2011 3.7 1463 52 30 2.9
Korosoglou et al., 2010b 2.0 1473 55 20 5.9
VASODILATOR STRESS CMR
Bertaso et al., 2013 1.8 362 43 25 4.7
Bingham and Hachamovitch, 2011 2.6 908 49 33 1.76
Bodi et al., 2007 1.1 1722 Not reported 41 1.15
Buckert et al., 2013 4.2 1152 Not reported 27 3.21
Coelho-Filho et al., 2011 2.5 405 Not reported 31 17.2
Doesch et al., 2009 2.5 81 100 56 16.6
Ingkanisorn et al., 2006 1.3 135 17 21 30.0
Jahnke et al., 2012 4.8 679 54 48 4.1
Krittayaphong et al., 2011 2.9 1232 12 34 9.7
Lerakis et al., 2009 0.8 103 13 10 Non-estimable
Lo et al., 2011 3.2 203 16 21 7.7
Lubbers et al., 2012 1.8 125 Not reported 10 Non-estimable
Pilz et al., 2008 1.0 218 0 0 Non-estimable
Steel et al., 2009 1.4 254 Not reported 29 8.04
Vogel-Claussen et al., 2009 1.2 27 19 19 Non-estimable

The assessment of myocardial viability using late gadolinium enhancement (LGE) is an established method for the assessment of infarct size and for the risk stratification of patients after acute myocardial infarction and with chronic ischemic heart disease (Gerber et al., 2002; Selvanayagam et al., 2004; Giannitsis et al., 2008; Larose et al., 2010). Thus, the presence and extent of LGE in terms of infarct size and transmurality is predictive of functional recovery in patients after acute infarction as well as in patients with chronic infarction who undergo coronary revascularization procedures. More recently, LGE was shown to be a predictor of poor cardiac outcomes in patients with suspected CAD and without history of myocardial infarction. In such patients, even small amounts of subendocardial LGE carried a high risk for future infarction and cardiac death (Kwong et al., 2006). Furthermore, LGE has revealed a higher prevalence of such unrecognized infarction even in community-based cohorts of older individuals and is associated with increased mortality risk (Barbier et al., 2011; Schelbert et al., 2012), even if some unrecognized infarctions are very small. In addition, we and others recently demonstrated that LGE has complementary value to both adenosine perfusion and high dose dobutamine CMR for the assessment of CAD and clinical outcomes (Steel et al., 2009; Bingham and Hachamovitch, 2011; Kelle et al., 2013).

An example of a patient with a small unrecognized scar of the apical anterior-lateral wall without detectable wall motion abnormality by cine images can be appreciated in Figure 6.

Patient undergoing CMR with late gadolinium enhancement (LGE) imaging, where a small scar of the apical anterior-lateral wall can be appreciated (red arrows in G), without detectable wall motion abnormalities in the corresponding cine images (A–F).

Recent studies also demonstrated the ability of quantitative myocardial deformation assessment using SENC to estimate cardiac outcomes (Korosoglou et al., 2011a). Thus, patients with impaired myocardial deformation exhibited a higher rate of cardiac death and non-fatal myocardial infarction compared to those with preserved myocardial deformation by strain and strain rate (Korosoglou et al., 2011a). Hereby, strain rate seems to better reflect changes in regional myocardial contractile behavior, in contrast to alterations in systolic strain, which can be related to increased heart rate during dobutamine stress or to altered myocardial loading conditions (Weidemann et al., 2002).

Ongoing clinical trials such as the PROMISE study now aim at comparing functional stress tests such as CMR and echocardiography with anatomical modalities such as CCTA in order to determine which might be better at finding out who has heart disease and will require more testing and treatment (https://www.promisetrial.org/). More than 10,000 have already been enrolled in this study and first results are expected in 2015.

 Cardiac computed tomography (CTA)

Cardiac Computed Tomography Angiography (CCTA) can provide non-invasive imaging of moving coronary arteries with sub-millimeter spatial resolution and high signal-to-noise ratio. This technique has seen rapid progress in its utility for the assessment of CAD in the last years and can provide delineation of both vessel lumen and coronary vessel wall. The latter enables the assessment of atherosclerotic plaque composition, which seems to be of great importance not only for the diagnostic classification but also for the estimation of future cardiac events in patients with suspected CAD. In contrast to CMR, the administration of iodine contrast agents is necessary with CCTA for the visualization of cardiac structures and coronary arteries.

In addition CCTA is associated with radiation exposure for the patients, which limits its serial applicability, particularly in younger patients (Einstein et al., 2007). This still raises concerns among physicians and radiologists with CCTA, as it may be associated with non-negligible lifetime attributable risk of breast or lung cancer. Therefore, several strategies have been developed lately in order to reduce the resultant radiation dosages (Hausleiter et al., 2010; Hosch et al., 2011, 2012).

Diagnosis of coronary artery disease

Several studies have demonstrated the ability of CCTA to detect anatomically significant CAD with high negative predictive value and clinically acceptable overall accuracy. Previous studies performed with 16-slice CT scanners, already pointed to the high negative predictive value of the technique (Nieman et al., 2002; Ropers et al., 2003; Kuettner et al., 2004; Mollet et al., 2004; Dewey et al., 2006), i.e., its ability to exclude relevant CAD with high accuracy (Table 4A). Subsequent studies, performed with 64-slice scanners confirmed the high negative predictive value of CCTA for the exclusion of anatomically relevant CAD, showing overall increased accuracy compared to previous studies (Heuschmid et al., 2007; Leber et al., 2007; Meijboom et al., 2007; Ropers et al., 2007; Shabestari et al., 2007; Miller et al., 2008), (Table 4B). Importantly, the ability of CCTA to detect CAD using X-Ray angiography as a gold standard is related to the pre-test probability of the study cohort. In this regard, a negative CCTA scan can reliably rule out the presence of significant CAD in patients with a low or intermediate likelihood for CAD, whereas it does not necessarily provide additional diagnostic information in patients with high pre-test probability (Meijboom et al., 2007). This reduction of the negative predictive values in patients with high disease prevalence was also shown in a comparable study comprising 88 patients (Husmann et al., 2008). Such high-risk symptomatic patients are likely to proceed to invasive angiography even if CCTA is negative, since the post-test probability of significant CAD is still >10%. CCTA therefore appears to have limited applicability in such patients, who should rather undergo a functional test as stress CMR for the assessment of inducible myocardial ischemia prior to invasive diagnostics. In the same line recent guidelines published by the European Society of Cardiology (ESC) recommend the usage of CCTA in rather patients at low intermediate (15–50%) pre-test probability for CAD, especially in candidates with low and stable heart rate and with therefore expected good image quality. In addition the presence of adequate technology and local expertise is important in this context (Montalescot et al., 2013).

Ability of representative 16-, 64- and >64-slice CCTA studies for the detection of anatomically significant CAD.

Study Number of patients Sensitivity (%) Specificity (%) PPV (%) NPV (%) Accuracy (%)
(A) 16-SLICE CCTA
Nieman et al., 2002 59 95 86 80 97 90
Ropers et al., 2003 77 92 93 79 97 93
Mollet et al., 2004 128 92 95 79 98 94
Kuettner et al., 2004 60 72 97 72 97 86
Dewey et al., 2006 129 82 90 90 95 87
Overview data 453 72–95 86–90 72–90 ≥95 86–94
(B) 64-SLICE CCTA
Meijboom et al., 2007 254 92 93 60 99 93
Shabestari et al., 2007 143 92 97 77 99 96
Leber et al., 2007 90 90 99 81 99 99
Ropers et al., 2007 100 90 98 79 99 98
Heuschmid et al., 2007 51 96 87 61 99 88
Miller et al., 2008 291 75 93 82 89 n.a
Overview data 929 75–96 87–99 60–82 89–99 88–99
(C) >64-SLICE (128-, 256- & 320-SLICE) CCTA
Blank et al., 2014 65 95 54 47 96 n.a.
Petcherski et al., 2013 121 97 97 75 100 97
Chao et al., 2010 104 94 95 78 99 94
Korosoglou et al., 2010c 27 89 100 100 95 96
Dewey et al., 2009 30 78 98 75 99 97
Li et al., 2013 454 87 97 98 83 96
Achenbach et al., 2011 50 92 98 74 99 95
Overview data 851 78–97 54–100 47–100 ≥95 ≥94

More recent studies, performed with >64-slice CT scanners confirmed the high negative predictive value of CCTA for the exclusion of anatomically significant CAD (Dewey et al., 2009; Chao et al., 2010; Korosoglou et al., 2010c; Achenbach et al., 2011; Li et al., 2013; Petcherski et al., 2013; Blank et al., 2014). In this regard, the recent introduction of 640-slice CT scanners allows for the acquisition of the whole coronary artery tree within one heart beat so that no stitching is required during image reconstruction. The use of adaptive iterative dose reduction algorithms with this systems was shown to allow for coronary CTA with relatively low radiation exposure of 2.0–2.6 mSv (Yoo et al., 2013; Di Cesare et al., 2014).

An example of a high-grade proximal LAD lesion using 256-slice CCTA can be appreciated in a male patient with atypical angina using whole-heart (Figure 7A), longitudinal (Figure 7B), and multi-planar reconstructions (Figures 7C,D). Subsequent invasive coronary angiography confirmed the presence of the proximal LAD lesion (Figures 7E,F).

Whole heart reconstruction (A) of a male patient undergoing CCTA (256-slice iCT scanner, Philips Medical Systems, Best, The Netherlands) for suspected CAD due to atypical angina. A high-grade lesion of the proximal (red arrows) and an intermediate lesion (blue arrows) of the mid LAD can be appreciated in corresponding longitudinal (B) and curved multi-planar reconstructions (C,D). Subsequent invasive coronary angiography confirmed the presence of CAD in the proximal and mid LAD (E,F).

Currently, an individual patient data meta-analysis is intended within the PROSPERO database, which will include individual patient data originating from studies comparing CCTA to invasive X-Ray angiography (Schuetz et al., 2013). This meta-analysis will possibly address the important question of which patients benefit most from CCTA in terms of clinical presentation and risk profile. To date, the most frequent indication for CCTA is found in patients with low or intermediate likelihood for CAD in order to avoid unnecessary invasive procedures. Thus, clinicians and radiologist should be aware of limiting factors such as severe coronary calcification (Gitsioudis et al., 2014), prior PCI and stent placement, arrhythmia and high body-mass-index (Carrabba et al., 2010), which may result in a higher number of false positive results, leading to unnecessary invasive diagnostic procedures.

The cost-effectiveness of CCTA for the diagnostic work-up of patients with suspected CAD was systematically evaluated in a recent meta-analysis (Zeb et al., 2014). Hereby, CCTA represented a cost-effective diagnostic strategy in the evaluation of patients with stable chest pain and CAD prevalence of 10–50%, as well as in patients with acute chest pain and low risk for obstructive CAD. In such patients CCTA may be associated with less downstream testing, expedited patient management and safe exclusion of acute coronary syndromes. In patients with CAD prevalence of ≥70% however, invasive angiography should rather represent the first line diagnostic modality. In the same line the ROMICAT trial previously demonstrated that in patients with symptoms suggestive of coronary syndromes, incorporating CCTA into a triage strategy improved the efficiency of clinical decision making, without resulting in a significant increase of the overall costs of care (Hoffmann et al., 2012).

 Assessment of coronary plaque composition and risk stratification Assessment of plaque composition

Despite the fact that conventional X-ray coronary angiography still remains the gold standard for detection of CAD, this technique provides limited information on the composition of atherosclerotic plaque (Libby, 2002). CCTA on the other hand, provides the non-invasive visualization of coronary plaque composition with high precision (Achenbach et al., 2004; Voros et al., 2011). First generation CCTA scanners offered limited ability for the reliable detection of coronary lesions due to lower spatial and temporal resolution. The development of multi-slice CT scanners with faster gantry rotation speed, Z-direction focal-spot sampling and spherical detector design however, helped to circumvent such limitations (Ong et al., 2006; Stolzmann et al., 2008; Voros, 2009; Chao et al., 2010; Hsiao et al., 2010; de Graaf et al., 2010). In addition, recent software developments with dedicated post-processing tools constituted major steps toward the reliable and quantitative assessment of atherosclerotic plaque composition (Mollet et al., 2005; Hamon et al., 2006; Ropers et al., 2006; Pohle et al., 2007; Schmid et al., 2008; Korosoglou et al., 2010c). Such software tools allow for the quantitative assessment of (Murray and Lopez, 1997) total plaque volume (Myerburg et al., 1997) distribution of calcified and non-calcified content within the plaque and (Naghavi et al., 2003) mean plaque density in Hounsfield Units (HU) with low inter-observer variability and within a reasonable time-spent (Korosoglou et al., 2010c; Rinehart et al., 2011). Current guidelines of the Society of Cardiac Computed Tomography (SCCT) introduced a scheme for the visual characterization of different plaque types for clinical reporting (Raff et al., 2009). In general, the percentage of calcium content is <20% in non-calcified plaque, between 20 and 80% in party calcified (mixed) plaque and >80% in calcified plaque. The reproducibility of this qualitative assessment (calcified, non-calcified, mixed plaques) was shown to be good in terms of both intra- and inter-observer agreement (Lehman et al., 2009; Rinehart et al., 2011). According to the tissue specific attenuation properties, 3 different plaque components can potentially be distinguished, including (Murray and Lopez, 1997) lipid-rich (14–70 HU), (Myerburg et al., 1997) fibrotic (71–150 HU) and (Naghavi et al., 2003) calcified components (>150–200 HU) (Pohle et al., 2007). However, there is still a lack of a uniform attenuation cut-off values defining these tissue qualities due to overlapping attenuation intervals, so that lipid and fibrotic plaque components are often summarized as “non-calcified.” Representative examples of a partly calcified atherosclerotic coronary plaque can be appreciated in Figure 8. Hereby, the complexity of this plaque in the left main coronary artery can be appreciated in corresponding multi-planar (Figures 8A,C), longitudinal (Figure 8B) and circumferential (Figures 8D,E) CCTA reconstructions. The presence of a high-grade left main lesion can be appreciated by invasive coronary angiography (Figure 8F).

A party calcified plaque in the left main coronary artery can be appreciated in corresponding multi-planar (A,C), longitudinal (B) and circumferential (D,E) CCTA reconstructions (red and blue arrows in B and C pointing to non-calcified and calcified components of the plaque, respectively). The presence of a high-grade left main lesion was subsequently confirmed by invasive coronary angiography (F).

 Estimation of clinical outcomes by CCTA

Several studies evaluated the ability of atherosclerotic plaque composition assessment by CCTA to estimate cardiac outcomes in patients with suspected or known CAD and clinically stable chest pain syndrome (Pundziute et al., 2007; Gaemperli et al., 2008; Aldrovandi et al., 2009; Carrigan et al., 2009; Gopal et al., 2009; Hadamitzky et al., 2009; Rubinshtein et al., 2009; van Werkhoven et al., 2009a, reviewed in Bamberg et al., 2011) and summarized in Table 5). The recently published meta-analysis, which systematically reviewed the findings of these studies, included 7335 patients with stable CAD (Bamberg et al., 2011). Hereby, the presence and extent of plaque and coronary lesions by CCTA were independent predictors of future cardiovascular events. Based on 252 outcome events (6% all-cause, 6% cardiovascular mortality, 23% non-fatal MI, 4% unstable angina and 62% coronary revascularization), the estimated hazard ratio was 10.7, indicating a more than 10-fold higher risk among patients with vs. without obstructive CAD. In addition, subjects with any coronary plaque were at ~4.5-fold risk for future events, compared to patients without plaque.

Studies investigating the ability of CCTA for the assessment of clinical outcomes by evaluation of (A) coronary artery stenosis and (B) atherosclerotic plaque.

Study Number of patients Median follow-up time (years) Event rate in all patients (%) Event rate in CT positive patients (%) Event rate in CT negative patients (%) Hazard ratios
(A) PREDICTION OF OUTCOMES BY CORONARY ARTERY STENOSIS
Pundziute et al., 2007 100 2.2 26 58 8 28.0
Gaemperli et al., 2008 220 1.2 23 51 2 12.7
Carrigan et al., 2009 227 2.3 3.5 13 0.5 9.8
Gopal et al., 2009 493 3.3 1.2 6.5 0.1 16.6
Hadamitzky et al., 2009 1150 1.5 1.2 3.3 0.3 16.1
Aldrovandi et al., 2009 187 2.0 5.4 24.3 1.0 34.9
Rubinshtein et al., 2009 545 1.5 6.4 14.5 1.0 10.9
van Werkhoven et al., 2009b 432 1.8 2.9 6.5 2.5 3.6
van Werkhoven et al., 2009a 316 1.8 2.2 6.0 1.7 3.5
Andreini et al., 2012 1304 4.3 2.6 19.9 0 4.8
Motoyama et al., 2009 1059 2.6 0.8 22.3 0.5 22.8
Hadamitzky et al., 2011 2223 2.3 0.9 2.9 0.3 13.5
(B) PREDICTION OF OUTCOMES BY CORONARY PLAQUE
Pundziute et al., 2007 100 2.2 24 30 0 n.a.
Gaemperli et al., 2008 220 1.2 23 28 0 n.a.
Ostrom et al., 2008 2538 6.5 0.5 0.72 0.26 n.a.
van Werkhoven et al., 2009b 432 1.8 1.9 4.9 1.4 n.a.
van Werkhoven et al., 2009a 316 1.8 1.3 3.5 0.64 n.a.

In the recently published CONFIRM registry both lumen narrowing and plaque burden, especially in proximal coronary segments were predictive of cardiovascular mortality in patients with suspected CAD (Hadamitzky et al., 2013). In this study, patients with proximal segments with stenosis >50% exhibited higher mortality rates (HR = 1.46 with a 95%CI of 1.15–1.87) compared to those without proximal coronary stenosis. In this regard, the number of proximal segments with stenosis >50% and the number of proximal segments with mixed or calcified plaque were identified as the best predictors of outcome surpassing the value provided by standard clinical variables, including the Framingham and the Morise score. In addition, the value of risk assessment in patients with CAD using a CCTA-based semi-automated plaque assessment has been recently shown (Versteylen et al., 2013). In this regard, quantitatively assessed total plaque and total non-calcified volume were predictive for future acute coronary syndromes, providing incremental value over clinical risk profiling and conventional CCTA readings.

 The role of biomarkers in combination with imaging (bio-imaging)

Fewer studies have investigated the complementary value of cardiac biomarkers to CCTA imaging findings for the estimation of cardiac outcomes so far. Several biomarkers are used in clinical routine together with clinical assessment and 12-lead ECG for the triage of patients with acute coronary syndrome (ACS). In this regard, cardiac troponins were shown to aid the diagnostic classification and risk stratification of such patients (Katus et al., 1991; Korosoglou et al., 2004; Thygesen et al., 2012). Recently, we and others demonstrated an association between atherosclerotic plaque composition by CCTA and high-sensitivity cardiac troponin even in non-ACS patients (Laufer et al., 2010; Korosoglou et al., 2011b). This association may be explained by chronic clinically silent rupture of non-calcified plaque, which results to embolization of atherosclerotic debris in the microcirculation and to consecutive myocardial micro-necrosis. In a further experimental setting, HMBG1 (high mobility group box 1) protein was found to be a critical mediator of acute ischemic injury, predicting adverse outcomes after myocardial infarction (Andrassy et al., 2008, 2011). In addition, we could show that HMBG1 serum levels are associated with coronary calcification and with non-calcified plaque composition in patients with suspected or known stable CAD (Andrassy et al., 2012).

C-reactive protein (CRP) on the other hand, was previously proposed as a central mediator in atherosclerotic plaque development and vascular inflammation (Zhang et al., 1999). However, further basic science research questioned such initially proposed direct atherogenic mechanisms (Clapp et al., 2005; Koike et al., 2009). In this regard, we and others demonstrated that serum levels of high sensitivity CRP are only weakly and not independently associated with plaque composition (Hamirani et al., 2008; Blaha et al., 2011; Korosoglou et al., 2011b). More specific inflammatory markers of such as HMBG1 could provide a stronger association with plaque formation in this context. In this regard, the recently published dal-PLAQUE study demonstrated that myeloperoxidase (MPO) levels are associated with carotid plaque inflammation, assessed using 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) (Duivenvoorden et al., 2013). An overview of studies within the bio-imaging area (Laufer et al., 2010; Blaha et al., 2011; Korosoglou et al., 2011b; Andrassy et al., 2012; Duivenvoorden et al., 2013; Nakazato et al., 2013; Voros et al., 2013) is presented in Table 6. Future studies are now warranted in order to investigate the ability of CCTA in combination with cardiac or inflammatory biomarkers for the individualized risk stratification of patients with presumably stable CAD.

“Bio-imaging” studies using coronary computed tomography and biomarkers in stable CAD patients.

Bio-markers CT Imaging technique Number of patients Main result/ conclusion
Laufer et al., 2010 hsTnT 64-slice CT 615 HsTnT strongly is associated with CAD in patients without ACS.
Korosoglou et al., 2011b hsTnT 256-slice CT 124 HsTnT is closely related to coronary plaque composition.
Blaha et al., 2011 hsCRP 4-slice CT for CAC 6762 hsCRP is not associated with coronary calcification.
Duivenvoorden et al., 2013 Myeloperoxidase (MPO), hsCRP 18FDG-PET/CT 130 MPO levels are associated with carotid plaque inflammation.
Andrassy et al., 2012 HMBG-1 256-slice CT 152 HMBG1 is associated with the atherosclerotic plaque composition.
Nakazato et al., 2013 LDL, HDL and total cholesterol ≥64-slice CT 4575 Non-HDL is associated with non-calcified coronary plaque.
Voros et al., 2013 ApoB, HDL, LDL 64-sl. MDCT IVUS/VH 60 ApoB and small HDL particles are associated with larger plaque burden and non-calcified plaque.

CAD, Coronary artery disease; LDL, low-density lipoprotein; HDL, high-density lipoprotein; ApoB, Apolipoprotein B; hsTnT, high-sensitive Troponin T; hsCRP, high-sensitive C-reactive protein; MPO, myeloperoxidase; CT, computer tomography; CAC, coronary artery calcification.

 Radiation exposure with CCTA

Optimal diagnostic image quality with a minimum dosage of radiation exposure for the patients still represents a major challenge. In this regard, radiation exposure with CCTA still raises concerns among physicians, as it may be associated with non-negligible lifetime attributable risk of breast or lung cancer, particularly in women and in younger patients (Einstein et al., 2007). In one of the first studies, which systematically investigated the radiation dose of CCTA in routine clinical practice, median CCTA doses were shown to be extremely different among different study sites and CT scanners (Hausleiter et al., 2009). Since then several strategies have been developed to reduce radiation dose, including dose modulation techniques, prospective ECG triggering, low-tube voltage CT imaging and iterative reconstruction algorithms (Hausleiter et al., 2010; Hosch et al., 2011, 2012, 2013). In this regard, the PROTECTION I study demonstrated that prospective ECG-triggered CCTA can significantly reduce radiation dose by ~70%, without influencing image quality when compared to standard retrospective scans in patients with a low and stable heart rate (Bischoff et al., 2010). These results were subsequently confirmed in the multicenter, multivendor, randomized PROTECTION III study (Hausleiter et al., 2012). The PROTECTION II study on the other hand, demonstrated that 100kV low tube voltage CCTA is associated with a further significant ~30% reduction of the resultant radiation exposure with simultaneously maintained diagnostic image quality (Hausleiter et al., 2010). More recently, the introduction of prospectively triggered high-pitch spiral CCTA allowed the acquisition of diagnostic images with a resultant radiation exposure of <1mSv in non-obese patients with low and stable heart rates (Achenbach et al., 2011). The combination of this new high-pitch spiral technology with low tube voltage and iterative reconstruction can further dramatically reduce radiation exposure with CCTA, achieving an effective dose below 0.1mSv with sufficient image quality (Schuhbaeck et al., 2013). However, such an ultra-low protocol may be associated with a non-negligible number of non-diagnostic segments even in non-obese patients with stable heart rates. In general CCTA can be nowadays assessed with a radiation exposure of ~0.5–1 mSv in most patients, by combining the use of prospective ECG-triggering, low-tube voltage, BMI-adapted protocols and iterative reconstruction algorithms. Representative images of a left coronary artery, reconstructed using standard back filtered (Figure 9A) and iterative algorithms (Figures 9B,C) with a resultant radiation exposure of 0.4 mSv can be appreciated in Figure 9.

Images of a left coronary artery, reconstructed using standard back filtered (A) and iterative algorithms [iDose in B and knowledge based iterative model reconstruction (IMR) in C] with a resultant radiation exposure of 0.4 mSv. Diagnostic image quality and significant noise reduction is provided using IMR.

In addition, the value of calcium scoring scans as a filter prior to CCTA, in order to identify patients with severe calcification was recently shown to be limited in younger patients with intermediate risk profile. Omitting such calcium scoring pre-scans in younger patients can contribute to further absolute dose reduction of ~0.75–1.0 mSv with cardiac CT studies (Gitsioudis et al., 2014). This is important in light of the clinical applicability of current low-dose CCTA protocols (as shown in Figure 9) and of the fact that additional calcium scoring scans resulted in additional DNA double-strand breaks in recent clinical trials (Brand et al., 2012).

 Summary and conclusions

Coronary computed tomography angiography and CMR can both be regarded as in the meanwhile clinically well-established techniques for the diagnostic classification and risk stratification of patients with suspected or known CAD. The strengths of CCTA are its ability (1) to non-invasively visualize moving coronary vessels with high spatial resolution, excluding significant CAD with high precision and (2) to assess the composition of atherosclerotic plaque components. Its main limitation is the resultant radiation exposure for the patients, which limits its serial applicability particularly in younger patients. However, scientist, clinicians, and manufacturers managed significant reductions of radiation exposure in this field within the last 5 years. The strength of CMR on the other hand, is its ability to assess inducible wall motion abnormalities and perfusion defects during stress testing aiding the detection of functionally significant CAD. Thus, it represents the optimal technique for the risk stratification of patients with suspected CAD and for guiding revascularization procedures in patients with diagnosed CAD by CCTA or invasive angiography. Current guidelines encourage the liberal use of both CCTA and CMR as first choice modalities for the diagnostic work-up of patients with low and intermediate likelihood for CAD in experienced centers.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

 References Achenbach S. Goroll T. Seltmann M. Pflederer T. Anders K. Ropers D. . (2011). Detection of coronary artery stenoses by low-dose, prospectively ECG-triggered, high-pitch spiral coronary CT angiography. JACC Cardiovasc. Imaging 4, 328–337. 10.1016/j.jcmg.2011.01.01221492807 Achenbach S. Moselewski F. Ropers D. Ferencik M. Hoffmann U. MacNeill B. . (2004). Detection of calcified and noncalcified coronary atherosclerotic plaque by contrast-enhanced, submillimeter multidetector spiral computed tomography: a segment-based comparison with intravascular ultrasound. Circulation 109, 14–17. 10.1161/01.CIR.0000111517.69230.0F14691045 Aldrovandi A. Maffei E. Palumbo A. Seitun S. Martini C. Brambilla V. . (2009). Prognostic value of computed tomography coronary angiography in patients with suspected coronary artery disease: a 24-month follow-up study. Eur. Radiol. 19, 1653–1660. 10.1007/s00330-009-1344-319224218 Andrassy M. Volz H. C. Igwe J. C. Funke B. Eichberger S. N. Kaya Z. . (2008). High-mobility group box-1 in ischemia-reperfusion injury of the heart. Circulation 117, 3216–3226. 10.1161/CIRCULATIONAHA.108.76933118574060 Andrassy M. Volz H. C. Riedle N. Gitsioudis G. Seidel C. Laohachewin D. . (2011). HMGB1 as a predictor of infarct transmurality and functional recovery in patients with myocardial infarction. J. Intern. Med. 270, 245–253. 10.1111/j.1365-2796.2011.02369.x21362071 Andrassy M. Volz H. C. Schuessler A. Gitsioudis G. Hofmann N. Laohachewin D. . (2012). HMGB1 is associated with atherosclerotic plaque composition and burden in patients with stable coronary artery disease. PLoS ONE 7:e52081. 10.1371/journal.pone.005208123284878 Andreini D. Pontone G. Mushtaq S. Bartorelli A. L. Bertella E. Antonioli L. . (2012). A long-term prognostic value of coronary CT angiography in suspected coronary artery disease. JACC Cardiovasc. Imaging 5, 690–701. 10.1016/j.jcmg.2012.03.00922789937 Bamberg F. Sommer W. H. Hoffmann V. Achenbach S. Nikolaou K. Conen D. . (2011). Meta-analysis and systematic review of the long-term predictive value of assessment of coronary atherosclerosis by contrast-enhanced coronary computed tomography angiography. J. Am. Coll. Cardiol. 57, 2426–2436. 10.1016/j.jacc.2010.12.04321658564 Barbier C. E. Nylander R. Themudo R. Ahlstrom H. Lind L. Larsson E. M. . (2011). Prevalence of unrecognized myocardial infarction detected with magnetic resonance imaging and its relationship to cerebral ischemic lesions in both sexes. J. Am. Coll. Cardiol. 58, 1372–1377. 10.1016/j.jacc.2011.06.02821920267 Bertaso A. G. Richardson J. D. Wong D. T. Cunnington M. S. Nelson A. J. Tayeb H. . (2013). Prognostic value of adenosine stress perfusion cardiac MRI with late gadolinium enhancement in an intermediate cardiovascular risk population. Int. J. Cardiol. 167, 2055–2060. 10.1016/j.ijcard.2012.05.05122664364 Bingham S. E. Hachamovitch R. (2011). Incremental prognostic significance of combined cardiac magnetic resonance imaging, adenosine stress perfusion, delayed enhancement, and left ventricular function over preimaging information for the prediction of adverse events. Circulation 123, 1509–1518. 10.1161/CIRCULATIONAHA.109.90765921444886 Bischoff B. Hein F. Meyer T. Krebs M. Hadamitzky M. Martinoff S. . (2010). Comparison of sequential and helical scanning for radiation dose and image quality: results of the Prospective Multicenter Study on Radiation Dose Estimates of Cardiac CT Angiography (PROTECTION) I Study. AJR Am. J. Roentgenol. 194, 1495–1499. 10.2214/AJR.09.354320489088 Blaha M. J. Rivera J. J. Budoff M. J. Blankstein R. Agatston A. O'Leary D. H. . (2011). Association between obesity, high-sensitivity C-reactive protein > / =2 mg/L, and subclinical atherosclerosis: implications of JUPITER from the Multi-Ethnic Study of Atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 31, 1430–1438. 10.1161/ATVBAHA.111.22376821474823 Blank N. Gaspar T. Halon D. A. Peled N. Petcherski O. Lewis B. S. . (2014). Computer-assisted diagnosis of obstructive coronary atherosclerosis in patients undergoing 256-slice coronary computed tomography angiography: a comparison with invasive coronary angiography. Int. J. Cardiol. 172, e130–e131. 10.1016/j.ijcard.2013.12.11224439780 Boden W. E. O'Rourke R. A. Teo K. K. Hartigan P. M. Maron D. J. Kostuk W. J. . (2007). Optimal medical therapy with or without PCI for stable coronary disease. N. Engl. J. Med. 356, 1503–1516. 10.1056/NEJMoa07082917387127 Bodi V. Sanchis J. Lopez-Lereu M. P. Nunez J. Mainar L. Monmeneu J. V. . (2007). Prognostic value of dipyridamole stress cardiovascular magnetic resonance imaging in patients with known or suspected coronary artery disease. J. Am. Coll. Cardiol. 50, 1174–1179. 10.1016/j.jacc.2007.06.016 Brand M. Sommer M. Achenbach S. Anders K. Lell M. Lobrich M. . (2012). X-ray induced DNA double-strand breaks in coronary CT angiography: comparison of sequential, low-pitch helical and high-pitch helical data acquisition. Eur. J. Radiol. 81, e357–e362. 10.1016/j.ejrad.2011.11.02722178288 Buckert D. Dewes P. Walcher T. Rottbauer W. Bernhardt P. (2013). Intermediate-term prognostic value of reversible perfusion deficit diagnosed by adenosine CMR: a prospective follow-up study in a consecutive patient population. JACC Cardiovasc. Imaging 6, 56–63. 10.1016/j.jcmg.2012.08.01123328562 Carrabba N. Schuijf J. D. de Graaf F. R. Parodi G. Maffei E. Valenti R. . (2010). Diagnostic accuracy of 64-slice computed tomography coronary angiography for the detection of in-stent restenosis: a meta-analysis. J. Nucl. Cardiol. 17, 470–478. 10.1007/s12350-010-9218-220379863 Carrigan T. P. Nair D. Schoenhagen P. Curtin R. J. Popovic Z. B. Halliburton S. . (2009). Prognostic utility of 64-slice computed tomography in patients with suspected but no documented coronary artery disease. Eur. Heart J. 30, 362–371. 10.1093/eurheartj/ehn60519153177 Chao S. P. Law W. Y. Kuo C. J. Hung H. F. Cheng J. J. Lo H. M. . (2010). The diagnostic accuracy of 256-row computed tomographic angiography compared with invasive coronary angiography in patients with suspected coronary artery disease. Eur. Heart J. 31, 1916–1923. 10.1093/eurheartj/ehq07220233790 Charoenpanichkit C. Morgan T. M. Hamilton C. A. Wallace E. L. Robinson K. Ntim W. O. . (2010). Left ventricular hypertrophy influences cardiac prognosis in patients undergoing dobutamine cardiac stress testing. Circ. Cardiovasc. Imaging. 3, 392–397. 10.1161/CIRCIMAGING.109.91207120442370 Clapp B. R. Hirschfield G. M. Storry C. Gallimore J. R. Stidwill R. P. Singer M. . (2005). Inflammation and endothelial function: direct vascular effects of human C-reactive protein on nitric oxide bioavailability. Circulation 111, 1530–1536. 10.1161/01.CIR.0000159336.31613.3115795363 Coelho-Filho O. R. Seabra L. F. Mongeon F. P. Abdullah S. M. Francis S. A. Blankstein R. . (2011). Stress myocardial perfusion imaging by CMR provides strong prognostic value to cardiac events regardless of patient's sex. JACC Cardiovasc. Imaging 4, 850–861. 10.1016/j.jcmg.2011.04.01521835377 Cury R. C. Cattani C. A. Gabure L. A. Racy D. J. de Gois J. M. Siebert U. . (2006). Diagnostic performance of stress perfusion and delayed-enhancement MR imaging in patients with coronary artery disease. Radiology 240, 39–45. 10.1148/radiol.240105116116793971 de Graaf F. R. Schuijf J. D. van Velzen J. E. Kroft L. J. de Roos A. Reiber J. H. . (2010). Diagnostic accuracy of 320-row multidetector computed tomography coronary angiography in the non-invasive evaluation of significant coronary artery disease. Eur. Heart J. 31, 1908–1915. 10.1093/eurheartj/ehp57120047991 Dewey M. Teige F. Schnapauff D. Laule M. Borges A. C. Wernecke K. D. . (2006). Noninvasive detection of coronary artery stenoses with multislice computed tomography or magnetic resonance imaging. Ann. Intern. Med. 145, 407–415. 10.7326/0003-4819-145-6-200609190-0000416983128 Dewey M. Zimmermann E. Deissenrieder F. Laule M. Dubel H. P. Schlattmann P. . (2009). Noninvasive coronary angiography by 320-row computed tomography with lower radiation exposure and maintained diagnostic accuracy: comparison of results with cardiac catheterization in a head-to-head pilot investigation. Circulation 120, 867–875. 10.1161/CIRCULATIONAHA.109.85928019704093 Di Cesare E. Gennarelli A. Di Sibio A. Felli V. Splendiani A. Gravina G. L. . (2014). Assessment of dose exposure and image quality in coronary angiography performed by 640-slice CT: a comparison between adaptive iterative and filtered back-projection algorithm by propensity analysis. Radiol. Med. [Epub ahead of print]. 10.1007/s11547-014-0382-324553783 Doesch C. Seeger A. Doering J. Herdeg C. Burgstahler C. Claussen C. D. . (2009). Risk stratification by adenosine stress cardiac magnetic resonance in patients with coronary artery stenoses of intermediate angiographic severity. JACC Cardiovasc. Imaging 2, 424–433. 10.1016/j.jcmg.2008.11.01719580724 Doyle M. Fuisz A. Kortright E. Biederman R. W. Walsh E. G. Martin E. T. . (2003). The impact of myocardial flow reserve on the detection of coronary artery disease by perfusion imaging methods: an NHLBI WISE study. J. Cardiovasc. Magn. Reson. 5, 475–485. 10.1081/JCMR-12002226312882078 Duivenvoorden R. Mani V. Woodward M. Kallend D. Suchankova G. Fuster V. . (2013). Relationship of serum inflammatory biomarkers with plaque inflammation assessed by FDG PET/CT: the dal-PLAQUE study. JACC Cardiovasc. Imaging 6, 1087–1094. 10.1016/j.jcmg.2013.03.00924135322 Einstein A. J. Henzlova M. J. Rajagopalan S. (2007). Estimating risk of cancer associated with radiation exposure from 64-slice computed tomography coronary angiography. JAMA 298, 317–323. 10.1001/jama.298.3.31717635892 Fuster V. Badimon L. Badimon J. J. Chesebro J. H. (1992). The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N. Engl. J. Med. 326, 242–250. 10.1056/NEJM1992012332604061727977 Gaemperli O. Valenta I. Schepis T. Husmann L. Scheffel H. Desbiolles L. . (2008). Coronary 64-slice CT angiography predicts outcome in patients with known or suspected coronary artery disease. Eur. Radiol. 18, 1162–1173. 10.1007/s00330-008-0871-718286291 Gebker R. Frick M. Jahnke C. Berger A. Schneeweis C. Manka R. . (2012). Value of additional myocardial perfusion imaging during dobutamine stress magnetic resonance for the assessment of intermediate coronary artery disease. Int. J. Cardiovasc. Imaging 28, 89–97. 10.1007/s10554-010-9764-321153708 Gebker R. Jahnke C. Manka R. Hamdan A. Schnackenburg B. Fleck E. . (2008). Additional value of myocardial perfusion imaging during dobutamine stress magnetic resonance for the assessment of coronary artery disease. Circ. Cardiovasc. Imaging 1, 122–130. 10.1161/CIRCIMAGING.108.77910819808529 Gebker R. Jahnke C. Manka R. Hucko T. Schnackenburg B. Kelle S. . (2011). The role of dobutamine stress cardiovascular magnetic resonance in the clinical management of patients with suspected and known coronary artery disease. J. Cardiovasc. Magn. Reson. 13:46. 10.1186/1532-429X-13-4621910881 Gebker R. Mirelis J. G. Jahnke C. Hucko T. Manka R. Hamdan A. . (2010). Influence of left ventricular hypertrophy and geometry on diagnostic accuracy of wall motion and perfusion magnetic resonance during dobutamine stress. Circ. Cardiovasc. Imaging 3, 507–514. 10.1161/CIRCIMAGING.109.92367220576810 Gerber B. L. Garot J. Bluemke D. A. Wu K. C. Lima J. A. (2002). Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction. Circulation 106, 1083–1089. 10.1161/01.CIR.0000027818.15792.1E12196333 Giang T. H. Nanz D. Coulden R. Friedrich M. Graves M. Al-Saadi N. . (2004). Detection of coronary artery disease by magnetic resonance myocardial perfusion imaging with various contrast medium doses: first European multi-centre experience. Eur. Heart J. 25, 1657–1665. 10.1016/j.ehj.2004.06.03715351166 Giannitsis E. Steen H. Kurz K. Ivandic B. Simon A. C. Futterer S. . (2008). Cardiac magnetic resonance imaging study for quantification of infarct size comparing directly serial versus single time-point measurements of cardiac troponin T. J. Am. Coll. Cardiol. 51, 307–314. 10.1016/j.jacc.2007.09.04118206741 Gitsioudis G. Hosch W. Iwan J. Voss A. Atsiatorme E. Hofmann N. P. . (2014). When do we really need coronary calcium scoring prior to contrast-enhanced coronary computed tomography angiography? Analysis by age, gender and coronary risk factors. PLoS ONE 9:e92396. 10.1371/journal.pone.009239624714677 Gopal A. Nasir K. Ahmadi N. Gul K. Tiano J. Flores M. . (2009). Cardiac computed tomographic angiography in an outpatient setting: an analysis of clinical outcomes over a 40-month period. J. Cardiovasc. Comput. Tomogr. 3, 90–95. 10.1016/j.jcct.2009.01.00319269915 Greenwood J. P. Maredia N. Younger J. F. Brown J. M. Nixon J. Everett C. C. . (2012). Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial. Lancet 379, 453–460. 10.1016/S0140-6736(11)61335-422196944 Greenwood J. P. Motwani M. Maredia N. Brown J. M. Everett C. C. Nixon J. . (2014). Comparison of cardiovascular magnetic resonance and single-photon emission computed tomography in women with suspected coronary artery disease from the Clinical Evaluation of Magnetic Resonance Imaging in Coronary Heart Disease (CE-MARC) Trial. Circulation 129, 1129–1138. 10.1161/CIRCULATIONAHA.112.00007124357404 Hadamitzky M. Achenbach S. Al-Mallah M. Berman D. Budoff M. Cademartiri F. . (2013). Optimized prognostic score for coronary computed tomographic angiography: results from the CONFIRM registry (COronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter Registry). J. Am. Coll. Cardiol. 62, 468–476. 10.1016/j.jacc.2013.04.06423727215 Hadamitzky M. Distler R. Meyer T. Hein F. Kastrati A. Martinoff S. . (2011). Prognostic value of coronary computed tomographic angiography in comparison with calcium scoring and clinical risk scores. Circ. Cardiovasc. Imaging 4, 16–23. 10.1161/CIRCIMAGING.110.95535120884832 Hadamitzky M. Freissmuth B. Meyer T. Hein F. Kastrati A. Martinoff S. . (2009). Prognostic value of coronary computed tomographic angiography for prediction of cardiac events in patients with suspected coronary artery disease. JACC Cardiovasc. Imaging 2, 404–411. 10.1016/j.jcmg.2008.11.01519580721 Hall M. E. Miller C. D. Hundley W. G. (2012). Adenosine stress cardiovascular magnetic resonance-observation unit management of patients at intermediate risk for acute coronary syndrome: a possible strategy for reducing healthcare-related costs. Curr. Treat. Options Cardiovasc. Med. 14, 117–125. 10.1007/s11936-011-0156-322127744 Hamirani Y. S. Pandey S. Rivera J. J. Ndumele C. Budoff M. J. Blumenthal R. S. . (2008). Markers of inflammation and coronary artery calcification: a systematic review. Atherosclerosis 201, 1–7. 10.1016/j.atherosclerosis.2008.04.04518561934 Hamon M. Biondi-Zoccai G. G. Malagutti P. Agostoni P. Morello R. Valgimigli M. . (2006). Diagnostic performance of multislice spiral computed tomography of coronary arteries as compared with conventional invasive coronary angiography: a meta-analysis. J. Am. Coll. Cardiol. 48, 1896–1910. 10.1016/j.jacc.2006.08.02817084268 Hausleiter J. Martinoff S. Hadamitzky M. Martuscelli E. Pschierer I. Feuchtner G. M. . (2010). Image quality and radiation exposure with a low tube voltage protocol for coronary CT angiography results of the PROTECTION II Trial. JACC Cardiovasc. Imaging 3, 1113–1123. 10.1016/j.jcmg.2010.08.01621070998 Hausleiter J. Meyer T. Hermann F. Hadamitzky M. Krebs M. Gerber T. C. . (2009). Estimated radiation dose associated with cardiac CT angiography. JAMA 301, 500–507. 10.1001/jama.2009.5419190314 Hausleiter J. Meyer T. S. Martuscelli E. Spagnolo P. Yamamoto H. Carrascosa P. . (2012). Image quality and radiation exposure with prospectively ECG-triggered axial scanning for coronary CT angiography: the multicenter, multivendor, randomized PROTECTION-III study. JACC Cardiovasc. Imaging 5, 484–493. 10.1016/j.jcmg.2011.12.01722595156 Heuschmid M. Burgstahler C. Reimann A. Brodoefel H. Mysal I. Haeberle E. . (2007). Usefulness of noninvasive cardiac imaging using dual-source computed tomography in an unselected population with high prevalence of coronary artery disease. Am. J. Cardiol. 100, 587–592. 10.1016/j.amjcard.2007.03.06617697811 Hoffmann U. Truong Q. A. Schoenfeld D. A. Chou E. T. Woodard P. K. Nagurney J. T. . (2012). Coronary CT angiography versus standard evaluation in acute chest pain. N. Engl. J. Med. 367, 299–308. 10.1056/NEJMoa120116122830462 Hosch W. Heye T. Schulz F. Lehrke S. Schlieter M. Giannitsis E. . (2011). Image quality and radiation dose in 256-slice cardiac computed tomography: Comparison of prospective versus retrospective image acquisition protocols. Eur. J. Radiol. 80, 127–135. 10.1016/j.ejrad.2010.07.01120708867 Hosch W. Hofmann N. P. Mueller D. Iwan J. Gitsioudis G. Siebert S. . (2013). Body mass index-adapted prospective coronary computed tomography angiography. Determining the lowest limit for diagnostic purposes. Eur. J. Radiol. 82, e232–e239. 10.1016/j.ejrad.2012.12.01323332891 Hosch W. Stiller W. Mueller D. Gitsioudis G. Welzel J. Dadrich M. . (2012). Reduction of radiation exposure and improvement of image quality with BMI-adapted prospective cardiac computed tomography and iterative reconstruction. Eur. J. Radiol. 81, 3568–3576. 10.1016/j.ejrad.2011.06.05521784592 Hsiao E. M. Rybicki F. J. Steigner M. (2010). CT coronary angiography: 256-slice and 320-detector row scanners. Curr. Cardiol. Rep. 12, 68–75. 10.1007/s11886-009-0075-z20425186 Hundley W. G. Hamilton C. A. Thomas M. S. Herrington D. M. Salido T. B. Kitzman D. W. . (1999). Utility of fast cine magnetic resonance imaging and display for the detection of myocardial ischemia in patients not well suited for second harmonic stress echocardiography. Circulation 100, 1697–1702. 10.1161/01.CIR.100.16.169710525488 Husmann L. Schepis T. Scheffel H. Gaemperli O. Leschka S. Valenta I. . (2008). Comparison of diagnostic accuracy of 64-slice computed tomography coronary angiography in patients with low, intermediate, and high cardiovascular risk. Acad. Radiol. 15, 452–461. 10.1016/j.acra.2007.12.00818342770 Ingkanisorn W. P. Kwong R. Y. Bohme N. S. Geller N. L. Rhoads K. L. Dyke C. K. . (2006). Prognosis of negative adenosine stress magnetic resonance in patients presenting to an emergency department with chest pain. J. Am. Coll. Cardiol. 47, 1427–1432. 10.1016/j.jacc.2005.11.05916580532 Ishida N. Sakuma H. Motoyasu M. Okinaka T. Isaka N. Nakano T. . (2003). Noninfarcted myocardium: correlation between dynamic first-pass contrast-enhanced myocardial MR imaging and quantitative coronary angiography. Radiology 229, 209–216. 10.1148/radiol.229102111812944596 Jahnke C. Furundzija V. Gebker R. Manka R. Frick M. Schnackenburg B. . (2012). Gender-based prognostic value of pharmacological cardiac magnetic resonance stress testing: head-to-head comparison of adenosine perfusion and dobutamine wall motion imaging. Int. J. Cardiovasc. Imaging 28, 1087–1098. 10.1007/s10554-011-9919-x21732028 Jahnke C. Nagel E. Gebker R. Kokocinski T. Kelle S. Manka R. . (2007). Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging. Circulation 115, 1769–1776. 10.1161/CIRCULATIONAHA.106.65201617353441 Jahnke C. Paetsch I. Gebker R. Bornstedt A. Fleck E. Nagel E. (2006). Accelerated 4D dobutamine stress MR imaging with k-t BLAST: feasibility and diagnostic performance. Radiology 241, 718–728. 10.1148/radiol.241305152217065561 Katus H. A. Remppis A. Neumann F. J. Scheffold T. Diederich K. W. Vinar G. . (1991). Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation 83, 902–912. 10.1161/01.CIR.83.3.9021999039 Kawase Y. Nishimoto M. Hato K. Okajima K. Yoshikawa J. (2004). Assessment of coronary artery disease with nicorandil stress magnetic resonance imaging. Osaka City Med. J. 50, 87–94. 15819303 Kelle S. Chiribiri A. Vierecke J. Egnell C. Hamdan A. Jahnke C. . (2011). Long-term prognostic value of dobutamine stress CMR. JACC Cardiovasc. Imaging 4, 161–172. 10.1016/j.jcmg.2010.11.01221329901 Kelle S. Nagel E. Voss A. Hofmann N. Gitsioudis G. Buss S. J. . (2013). A bi-center cardiovascular magnetic resonance prognosis study focusing on dobutamine wall motion and late gadolinium enhancement in 3,138 consecutive patients. J. Am. Coll. Cardiol. 61, 2310–2312. 10.1016/j.jacc.2013.02.06323563138 Klem I. Heitner J. F. Shah D. J. Sketch M. H. Jr. Behar V. Weinsaft J. . (2006). Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging. J. Am. Coll. Cardiol. 47, 1630–1638. 10.1016/j.jacc.2005.10.07416631001 Koike T. Kitajima S. Yu Y. Nishijima K. Zhang J. Ozaki Y. . (2009). Human C-reactive protein does not promote atherosclerosis in transgenic rabbits. Circulation 120, 2088–2094. 10.1161/CIRCULATIONAHA.109.87279619901190 Korosoglou G. Elhmidi Y. Steen H. Schellberg D. Riedle N. Ahrens J. . (2010b). Prognostic value of high-dose dobutamine stress magnetic resonance imaging in 1,493 consecutive patients: assessment of myocardial wall motion and perfusion. J. Am. Coll. Cardiol. 56, 1225–1234. 10.1016/j.jacc.2010.06.02020883929 Korosoglou G. Futterer S. Humpert P. M. Riedle N. Lossnitzer D. Hoerig B. . (2009c). Strain-encoded cardiac MR during high-dose dobutamine stress testing: comparison to cine imaging and to myocardial tagging. J. Magn. Reson. Imaging 29, 1053–1061. 10.1002/jmri.2175919388131 Korosoglou G. Gitsioudis G. Voss A. Lehrke S. Riedle N. Buss S. J. . (2011a). Strain-encoded cardiac magnetic resonance during high-dose dobutamine stress testing for the estimation of cardiac outcomes: comparison to clinical parameters and conventional wall motion readings. J. Am. Coll. Cardiol. 58, 1140–1149. 10.1016/j.jacc.2011.03.06321884952 Korosoglou G. Labadze N. Hansen A. Selter C. Giannitsis E. Katus H. . (2004). Usefulness of real-time myocardial perfusion imaging in the evaluation of patients with first time chest pain. Am. J. Cardiol. 94, 1225–1231. 10.1016/j.amjcard.2004.07.10415541235 Korosoglou G. Lehrke S. Mueller D. Hosch W. Kauczor H. U. Humpert P. M. . (2011b). Determinants of troponin release in patients with stable coronary artery disease: insights from CT angiography characteristics of atherosclerotic plaque. Heart 97, 823–831. 10.1136/hrt.2010.19320120884786 Korosoglou G. Lehrke S. Wochele A. Hoerig B. Lossnitzer D. Steen H. . (2010a). Strain-encoded CMR for the detection of inducible ischemia during intermediate stress. JACC Cardiovasc. Imaging 3, 361–371. 10.1016/j.jcmg.2009.11.01520394897 Korosoglou G. Lossnitzer D. Schellberg D. Lewien A. Wochele A. Schaeufele T. . (2009b). Strain-encoded cardiac MRI as an adjunct for dobutamine stress testing: incremental value to conventional wall motion analysis. Circ. Cardiovasc. Imaging 2, 132–140. 10.1161/CIRCIMAGING.108.79010519808579 Korosoglou G. Mueller D. Lehrke S. Steen H. Hosch W. Heye T. . (2010c). Quantitative assessment of stenosis severity and atherosclerotic plaque composition using 256-slice computed tomography. Eur. Radiol. 20, 1841–1850. 10.1007/s00330-010-1753-320306078 Korosoglou G. Osman N. F. Dengler T. J. Riedle N. Steen H. Lehrke S. . (2009a). Strain-encoded cardiac magnetic resonance for the evaluation of chronic allograft vasculopathy in transplant recipients. Am. J. Transplant. 9, 2587–2596. 10.1111/j.1600-6143.2009.02769.x19843034 Korosoglou G. Weiss R. G. Kedziorek D. A. Walczak P. Gilson W. D. Schar M. . (2008a). Noninvasive detection of macrophage-rich atherosclerotic plaque in hyperlipidemic rabbits using “positive contrast” magnetic resonance imaging. J. Am. Coll. Cardiol. 52, 483–491. 10.1016/j.jacc.2008.03.06318672170 Korosoglou G. Youssef A. A. Bilchick K. C. Ibrahim el S. Lardo A. C. Lai S. . (2008b). Real-time fast strain-encoded magnetic resonance imaging to evaluate regional myocardial function at 3.0 Tesla: Comparison to conventional tagging. J. Magn. Reson. Imaging 27, 1012–1018. 10.1002/jmri.2131518407541 Kraitchman D. L. Sampath S. Castillo E. Derbyshire J. A. Boston R. C. Bluemke D. A. . (2003). Quantitative ischemia detection during cardiac magnetic resonance stress testing by use of FastHARP. Circulation 107, 2025–2030. 10.1161/01.CIR.0000062684.47526.4712668517 Krittayaphong R. Chaithiraphan V. Maneesai A. Udompanturak S. (2011). Prognostic value of combined magnetic resonance myocardial perfusion imaging and late gadolinium enhancement. Int. J. Cardiovasc. Imaging 27, 705–714. 10.1007/s10554-011-9863-921479846 Kuettner A. Trabold T. Schroeder S. Feyer A. Beck T. Brueckner A. . (2004). Noninvasive detection of coronary lesions using 16-detector multislice spiral computed tomography technology: initial clinical results. J. Am. Coll. Cardiol. 44, 1230–1237. 10.1016/j.jacc.2004.05.07915364324 Kwong R. Y. Chan A. K. Brown K. A. Chan C. W. Reynolds H. G. Tsang S. . (2006). Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 113, 2733–2743. 10.1161/CIRCULATIONAHA.105.57064818407541 Larose E. Rodes-Cabau J. Pibarot P. Rinfret S. Proulx G. Nguyen C. M. . (2010). Predicting late myocardial recovery and outcomes in the early hours of ST-segment elevation myocardial infarction traditional measures compared with microvascular obstruction, salvaged myocardium, and necrosis characteristics by cardiovascular magnetic resonance. J. Am. Coll. Cardiol. 55, 2459–2469. 10.1016/j.jacc.2010.02.03320510213 Laufer E. M. Mingels A. M. Winkens M. H. Joosen I. A. Schellings M. W. Leiner T. . (2010). The extent of coronary atherosclerosis is associated with increasing circulating levels of high sensitive cardiac troponin T. Arterioscler. Thromb. Vasc. Biol. 30, 1269–1275. 10.1161/ATVBAHA.109.20039420299689 Leber A. W. Johnson T. Becker A. von Ziegler F. Tittus J. Nikolaou K. . (2007). Diagnostic accuracy of dual-source multi-slice CT-coronary angiography in patients with an intermediate pretest likelihood for coronary artery disease. Eur. Heart J. 28, 2354–2360. 10.1093/eurheartj/ehm29417644815 Lehman S. J. Schlett C. L. Bamberg F. Lee H. Donnelly P. Shturman L. . (2009). Assessment of coronary plaque progression in coronary computed tomography angiography using a semiquantitative score. JACC Cardiovasc. Imaging 2, 1262–1270. 10.1016/j.jcmg.2009.07.00719909929 Lerakis S. McLean D. S. Anadiotis A. V. Janik M. Oshinski J. N. Alexopoulos N. . (2009). Prognostic value of adenosine stress cardiovascular magnetic resonance in patients with low-risk chest pain. J. Cardiovasc. Magn. Reson. 11, 37. 10.1186/1532-429X-11-3719772587 Li S. Liu J. Luo Y. Peng L. Ni Q. Wu H. . (2013). Diagnostic accuracy of noninvasive coronary angiography with 320-slice computed tomography in the clinical routine: results from four-year clinical registry at a single center. Int. J. Cardiol. 168, 5035–5036. 10.1016/j.ijcard.2013.07.22223953256 Libby P. (2001). Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 104, 365–372. 10.1161/01.CIR.104.3.36511457759 Libby P. (2002). Inflammation in atherosclerosis. Nature 420, 868–874. 10.1038/nature0132312490960 Libby P. Ridker P. M. Maseri A. (2002). Inflammation and atherosclerosis. Circulation 105, 1135–1143. 10.1161/hc0902.10435311877368 Lipinski M. J. McVey C. M. Berger J. S. Kramer C. M. Salerno M. (2013). Prognostic value of stress cardiac magnetic resonance imaging in patients with known or suspected coronary artery disease: a systematic review and meta-analysis. J. Am. Coll. Cardiol. 62, 826–838. 10.1016/j.jacc.2013.03.080 Lo K. Y. Leung K. F. Chu C. M. Loke K. L. Chan C. K. Yue C. S. (2011). Prognostic value of adenosine stress myocardial perfusion by cardiac magnetic resonance imaging in patients with known or suspected coronary artery disease. QJM 104, 425–432. 10.1093/qjmed/hcq238 Lubbers D. D. Rijlaarsdam-Hermsen D. Kuijpers D. Kerkhof M. Sijens P. E. van Dijkman P. R. . (2012). Performance of adenosine “stress-only” perfusion MRI in patients without a history of myocardial infarction: a clinical outcome study. Int. J. Cardiovasc. Imaging 28, 109–115. 10.1007/s10554-010-9775-021279694 Meijboom W. B. van Mieghem C. A. Mollet N. R. Pugliese F. Weustink A. C. van Pelt N. . (2007). 64-slice computed tomography coronary angiography in patients with high, intermediate, or low pretest probability of significant coronary artery disease. J. Am. Coll. Cardiol. 50, 1469–1475. 10.1016/j.jacc.2007.07.007 Miller C. D. Hwang W. Case D. Hoekstra J. W. Lefebvre C. Blumstein H. . (2011). Stress CMR imaging observation unit in the emergency department reduces 1-year medical care costs in patients with acute chest pain: a randomized study for comparison with inpatient care. JACC Cardiovasc. Imaging 4, 862–870. 10.1016/j.jcmg.2011.04.01621835378 Miller J. M. Rochitte C. E. Dewey M. Arbab-Zadeh A. Niinuma H. Gottlieb I. . (2008). Diagnostic performance of coronary angiography by 64-row CT. N. Engl. J. Med. 359, 2324–2336. 10.1056/NEJMoa080657619038879 Mollet N. R. Cademartiri F. Krestin G. P. McFadden E. P. Arampatzis C. A. Serruys P. W. . (2005). Improved diagnostic accuracy with 16-row multi-slice computed tomography coronary angiography. J. Am. Coll. Cardiol. 45, 128–132. 10.1016/j.jacc.2004.09.07415629386 Mollet N. R. Cademartiri F. Nieman K. Saia F. Lemos P. A. McFadden E. P. . (2004). Multislice spiral computed tomography coronary angiography in patients with stable angina pectoris. J. Am. Coll. Cardiol. 43, 2265–2270. 10.1016/j.jacc.2004.03.03215193691 Montalescot G. Sechtem U. Achenbach S. Andreotti F. Arden C. Budaj A. . (2013). 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur. Heart J. 34, 2949–3003. 10.1093/eurheartj/eht29623996286 Mordini F. E. Haddad T. Hsu L. Y. Kellman P. Lowrey T. B. Aletras A. H. . (2014). Diagnostic accuracy of stress perfusion CMR in comparison with quantitative coronary angiography: fully quantitative, semiquantitative, and qualitative assessment. JACC Cardiovasc. Imaging 7, 14–22. 10.1016/j.jcmg.2013.08.01424433707 Motoyama S. Sarai M. Harigaya H. Anno H. Inoue K. Hara T. . (2009). Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. J. Am. Coll. Cardiol. 54, 49–57. 10.1016/j.jacc.2009.02.06819555840 Murray C. J. Lopez A. D. (1997). Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 349, 1436–1442. 10.1016/S0140-6736(96)07495-89164317 Myerburg R. J. Interian A. Jr. Mitrani R. M. Kessler K. M. Castellanos A. (1997). Frequency of sudden cardiac death and profiles of risk. Am. J. Cardiol. 80, 10F–19F. 10.1016/S0002-9149(97)00477-39291445 Nagel E. Klein C. Paetsch I. Hettwer S. Schnackenburg B. Wegscheider K. . (2003). Magnetic resonance perfusion measurements for the noninvasive detection of coronary artery disease. Circulation 108, 432–437. 10.1161/01.CIR.0000080915.35024.A912860910 Nagel E. Lehmkuhl H. B. Bocksch W. Klein C. Vogel U. Frantz E. . (1999). Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation 99, 763–770. 10.1161/01.CIR.99.6.7639989961 Naghavi M. Libby P. Falk E. Casscells S. W. Litovsky S. Rumberger J. . (2003). From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation 108, 1664–1672. 10.1161/01.CIR.0000087480.94275.97 Nakazato R. Gransar H. Berman D. S. Cheng V. Y. Lin F. Y. Achenbach S. . (2013). Relationship of low- and high-density lipoproteins to coronary artery plaque composition by CT angiography. J. Cardiovasc. Comput. Tomogr. 7, 83–90. 10.1016/j.jcct.2013.01.00823622503 Nandalur K. R. Dwamena B. A. Choudhri A. F. Nandalur M. R. Carlos R. C. (2007). Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease: a meta-analysis. J. Am. Coll. Cardiol. 50, 1343–1353. 10.1016/j.jacc.2007.06.03017903634 Neizel M. Lossnitzer D. Korosoglou G. Schaufele T. Lewien A. Steen H. . (2009). Strain-encoded (SENC) magnetic resonance imaging to evaluate regional heterogeneity of myocardial strain in healthy volunteers: Comparison with conventional tagging. J. Magn. Reson. Imaging 29, 99–105. 10.1002/jmri.2161219097105 Nieman K. Cademartiri F. Lemos P. A. Raaijmakers R. Pattynama P. M. de Feyter P. J. (2002). Reliable noninvasive coronary angiography with fast submillimeter multislice spiral computed tomography. Circulation 106, 2051–2054. 10.1161/01.CIR.0000037222.58317.3D12379572 Ong T. K. Chin S. P. Liew C. K. Chan W. L. Seyfarth M. T. Liew H. B. . (2006). Accuracy of 64-row multidetector computed tomography in detecting coronary artery disease in 134 symptomatic patients: influence of calcification. Am. Heart J. 151, 1323.e1–1323.e6. 10.1016/j.ahj.2005.12.02716781246 Ostrom M. P. Gopal A. Ahmadi N. Nasir K. Yang E. Kakadiaris I. . (2008). Mortality incidence and the severity of coronary atherosclerosis assessed by computed tomography angiography. J. Am. Coll. Cardiol. 52, 1335–1343. 10.1016/j.jacc.2008.07.02718929245 Paetsch I. Jahnke C. Ferrari V. A. Rademakers F. E. Pellikka P. A. Hundley W. G. . (2006). Determination of interobserver variability for identifying inducible left ventricular wall motion abnormalities during dobutamine stress magnetic resonance imaging. Eur. Heart J. 27, 1459–1464. 10.1093/eurheartj/ehi88316613929 Paetsch I. Jahnke C. Wahl A. Gebker R. Neuss M. Fleck E. . (2004). Comparison of dobutamine stress magnetic resonance, adenosine stress magnetic resonance, and adenosine stress magnetic resonance perfusion. Circulation 110, 835–842. 10.1161/01.CIR.0000138927.00357.FB15289384 Pan L. Stuber M. Kraitchman D. L. Fritzges D. L. Gilson W. D. Osman N. F. (2006). Real-time imaging of regional myocardial function using fast-SENC. Magn. Reson. Med. 55, 386–395. 10.1002/mrm.2077016402379 Pennell D. J. Underwood S. R. Ell P. J. Swanton R. H. Walker J. M. Longmore D. B. (1990). Dipyridamole magnetic resonance imaging: a comparison with thallium-201 emission tomography. Br. Heart J. 64, 362–369. 10.1136/hrt.64.6.3622271342 Pennell D. J. Underwood S. R. Manzara C. C. Swanton R. H. Walker J. M. Ell P. J. . (1992). Magnetic resonance imaging during dobutamine stress in coronary artery disease. Am. J. Cardiol. 70, 34–40. 10.1016/0002-9149(92)91386-I1615867 Petcherski O. Gaspar T. Halon D. A. Peled N. Jaffe R. Molnar R. . (2013). Diagnostic accuracy of 256-row computed tomographic angiography for detection of obstructive coronary artery disease using invasive quantitative coronary angiography as reference standard. Am. J. Cardiol. 111, 510–515. 10.1016/j.amjcard.2012.10.03623206926 Pilz G. Bernhardt P. Klos M. Ali E. Wild M. Hofling B. (2006). Clinical implication of adenosine-stress cardiac magnetic resonance imaging as potential gatekeeper prior to invasive examination in patients with AHA/ACC class II indication for coronary angiography. Clin. Res. Cardiol. 95, 531–538. 10.1007/s00392-006-0422-716897145 Pilz G. Jeske A. Klos M. Ali E. Hoefling B. Scheck R. . (2008). Prognostic value of normal adenosine-stress cardiac magnetic resonance imaging. Am. J. Cardiol. 101, 1408–1412. 10.1016/j.amjcard.2008.01.01918471450 Plein S. Greenwood J. P. Ridgway J. P. Cranny G. Ball S. G. Sivananthan M. U. (2004). Assessment of non-ST-segment elevation acute coronary syndromes with cardiac magnetic resonance imaging. J. Am. Coll. Cardiol. 44, 2173–2181. 10.1016/j.jacc.2004.08.05615582315 Plein S. Radjenovic A. Ridgway J. P. Barmby D. Greenwood J. P. Ball S. G. . (2005). Coronary artery disease: myocardial perfusion MR imaging with sensitivity encoding versus conventional angiography. Radiology 235, 423–430. 10.1148/radiol.235204045415858084 Pohle K. Achenbach S. Macneill B. Ropers D. Ferencik M. Moselewski F. . (2007). Characterization of non-calcified coronary atherosclerotic plaque by multi-detector row CT: comparison to IVUS. Atherosclerosis 190, 174–180. 10.1016/j.atherosclerosis.2006.01.01316494883 Pundziute G. Schuijf J. D. Jukema J. W. Boersma E. de Roos A. van der Wall E. E. . (2007). Prognostic value of multislice computed tomography coronary angiography in patients with known or suspected coronary artery disease. J. Am. Coll. Cardiol. 49, 62–70. 10.1016/j.jacc.2006.07.07017207724 Raff G. L. Abidov A. Achenbach S. Berman D. S. Boxt L. M. Budoff M. J. . (2009). SCCT guidelines for the interpretation and reporting of coronary computed tomographic angiography. J. Cardiovasc. Comput. Tomogr. 3, 122–136. 10.1016/j.jcct.2009.01.00119272853 Rerkpattanapipat P. Gandhi S. K. Darty S. N. Williams R. T. Davis A. D. Mazur W. . (2003). Feasibility to detect severe coronary artery stenoses with upright treadmill exercise magnetic resonance imaging. Am. J. Cardiol. 92, 603–606. 10.1016/S0002-9149(03)00734-312943887 Rinehart S. Vazquez G. Qian Z. Murrieta L. Christian K. Voros S. (2011). Quantitative measurements of coronary arterial stenosis, plaque geometry, and composition are highly reproducible with a standardized coronary arterial computed tomographic approach in high-quality CT datasets. J. Cardiovasc. Comput. Tomogr. 5, 35–43. 10.1016/j.jcct.2010.09.00621131252 Ropers D. Baum U. Pohle K. Anders K. Ulzheimer S. Ohnesorge B. . (2003). Detection of coronary artery stenoses with thin-slice multi-detector row spiral computed tomography and multiplanar reconstruction. Circulation 107, 664–666. 10.1161/01.CIR.0000055738.31551.A912578863 Ropers D. Rixe J. Anders K. Kuttner A. Baum U. Bautz W. . (2006). Usefulness of multidetector row spiral computed tomography with 64- x 0.6-mm collimation and 330-ms rotation for the noninvasive detection of significant coronary artery stenoses. Am. J. Cardiol. 97, 343–348. 10.1016/j.amjcard.2005.08.05016442393 Ropers U. Ropers D. Pflederer T. Anders K. Kuettner A. Stilianakis N. I. . (2007). Influence of heart rate on the diagnostic accuracy of dual-source computed tomography coronary angiography. J. Am. Coll. Cardiol. 50, 2393–2398. 10.1016/j.jacc.2007.09.01718154964 Rubinshtein R. Halon D. A. Gaspar T. Peled N. Lewis B. S. (2009). Cardiac computed tomographic angiography for risk stratification and prediction of late cardiovascular outcome events in patients with a chest pain syndrome. Int. J. Cardiol. 137, 108–115. 10.1016/j.ijcard.2008.06.03118718681 Sakuma H. Suzawa N. Ichikawa Y. Makino K. Hirano T. Kitagawa K. . (2005). Diagnostic accuracy of stress first-pass contrast-enhanced myocardial perfusion MRI compared with stress myocardial perfusion scintigraphy. AJR Am. J. Roentgenol. 185, 95–102. 10.2214/ajr.185.1.0185009515972407 Schalla S. Klein C. Paetsch I. Lehmkuhl H. Bornstedt A. Schnackenburg B. . (2002). Real-time MR image acquisition during high-dose dobutamine hydrochloride stress for detecting left ventricular wall-motion abnormalities in patients with coronary arterial disease. Radiology. 224, 845–851. 10.1148/radiol.224301094512202724 Schelbert E. B. Cao J. J. Sigurdsson S. Aspelund T. Kellman P. Aletras A. H. . (2012). Prevalence and prognosis of unrecognized myocardial infarction determined by cardiac magnetic resonance in older adults. JAMA 308, 890–896. 10.1001/2012.jama.1108922948699 Schmid M. Pflederer T. Jang I. K. Ropers D. Sei K. Daniel W. G. . (2008). Relationship between degree of remodeling and CT attenuation of plaque in coronary atherosclerotic lesions: an in-vivo analysis by multi-detector computed tomography. Atherosclerosis 197, 457–464. 10.1016/j.atherosclerosis.2007.07.00317727859 Schuetz G. M. Schlattmann P. Achenbach S. Budoff M. Garcia M. J. Roehle R. . (2013). Individual patient data meta-analysis for the clinical assessment of coronary computed tomography angiography: protocol of the Collaborative Meta-Analysis of Cardiac CT (CoMe-CCT). Syst. Rev. 2, 13. 10.1186/2046-4053-2-1323414575 Schuhbaeck A. Achenbach S. Layritz C. Eisentopf J. Hecker F. Pflederer T. . (2013). Image quality of ultra-low radiation exposure coronary CT angiography with an effective dose <0.1 mSv using high-pitch spiral acquisition and raw data-based iterative reconstruction. Eur. Radiol. 23, 597–606. 10.1007/s00330-012-2656-222983283 Schwitter J. Nanz D. Kneifel S. Bertschinger K. Buchi M. Knusel P. R. . (2001). Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography. Circulation 103, 2230–2235. 10.1161/01.CIR.103.18.223011342469 Schwitter J. Wacker C. M. Wilke N. Al-Saadi N. Sauer E. Huettle K. . (2012). Superior diagnostic performance of perfusion-cardiovascular magnetic resonance versus SPECT to detect coronary artery disease: the secondary endpoints of the multicenter multivendor MR-IMPACT II (Magnetic Resonance Imaging for Myocardial Perfusion Assessment in Coronary Artery Disease Trial). J. Cardiovasc. Magn. Reson. 14, 61. 10.1186/1532-429X-14-6122938651 Schwitter J. Wacker C. M. Wilke N. Al-Saadi N. Sauer E. Huettle K. . (2013). MR-IMPACT II: Magnetic Resonance Imaging for Myocardial Perfusion Assessment in Coronary artery disease Trial: perfusion-cardiac magnetic resonance vs. single-photon emission computed tomography for the detection of coronary artery disease: a comparative multicentre, multivendor trial. Eur. Heart J. 34, 775–781. 10.1093/eurheartj/ehs02222390914 Selvanayagam J. B. Kardos A. Francis J. M. Wiesmann F. Petersen S. E. Taggart D. P. . (2004). Value of delayed-enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization. Circulation 110, 1535–1541. 10.1161/01.CIR.0000142045.22628.7415353496 Shabestari A. A. Abdi S. Akhlaghpoor S. Azadi M. Baharjoo H. Pajouh M. D. . (2007). Diagnostic performance of 64-channel multislice computed tomography in assessment of significant coronary artery disease in symptomatic subjects. Am. J. Cardiol. 99, 1656–1661. 10.1016/j.amjcard.2007.01.04017560870 Smulders M. W. Kietselaer B. L. Das M. Wildberger J. E. Crijns H. J. Veenstra L. F. . (2013). The role of cardiovascular magnetic resonance imaging and computed tomography angiography in suspected non-ST-elevation myocardial infarction patients: design and rationale of the CARdiovascular Magnetic rEsoNance imaging and computed Tomography Angiography (CARMENTA) trial. Am. Heart J. 166, 968–975. 10.1016/j.ahj.2013.09.01224268210 Steel K. Broderick R. Gandla V. Larose E. Resnic F. Jerosch-Herold M. . (2009). Complementary prognostic values of stress myocardial perfusion and late gadolinium enhancement imaging by cardiac magnetic resonance in patients with known or suspected coronary artery disease. Circulation 120, 1390–1400. 10.1161/CIRCULATIONAHA.108.812503 Stolzmann P. Scheffel H. Leschka S. Plass A. Baumuller S. Marincek B. . (2008). Influence of calcifications on diagnostic accuracy of coronary CT angiography using prospective ECG triggering. AJR Am. J. Roentgenol. 191, 1684–1689. 10.2214/AJR.07.404019020236 Swirski F. K. Pittet M. J. Kircher M. F. Aikawa E. Jaffer F. A. Libby P. . (2006). Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease. Proc. Natl. Acad. Sci. U.S.A. 103, 10340–10345. 10.1073/pnas.060426010316801531 Takase B. Nagata M. Kihara T. Kameyawa A. Noya K. Matsui T. . (2004). Whole-heart dipyridamole stress first-pass myocardial perfusion MRI for the detection of coronary artery disease. Jpn. Heart J. 45, 475–486. 10.1536/jhj.45.47515240967 Thygesen K. Alpert J. S. Jaffe A. S. Simoons M. L. Chaitman B. R. White H. D. . (2012). Third universal definition of myocardial infarction. Circulation 126, 2020–2035. 10.1161/CIR.0b013e31826e105822923432 Topol E. J. Nissen S. E. (1995). Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ischemic heart disease. Circulation 92, 2333–2342. 10.1161/01.CIR.92.8.23337554219 Toussaint J. F. LaMuraglia G. M. Southern J. F. Fuster V. Kantor H. L. (1996). Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo. Circulation 94, 932–938. 10.1161/01.CIR.94.5.9328790028 Vallabhajosula S. Fuster V. (1997). Atherosclerosis: imaging techniques and the evolving role of nuclear medicine. J. Nucl. Med. 38, 1788–1796. 9374357 van Rugge F. P. van der Wall E. E. de Roos A. Bruschke A. V. (1993). Dobutamine stress magnetic resonance imaging for detection of coronary artery disease. J. Am. Coll. Cardiol. 22, 431–439. 10.1016/0735-1097(93)90047-58335812 van Rugge F. P. van der Wall E. E. Spanjersberg S. J. de Roos A. Matheijssen N. A. Zwinderman A. H. . (1994). Magnetic resonance imaging during dobutamine stress for detection and localization of coronary artery disease. Quantitative wall motion analysis using a modification of the centerline method. Circulation 90, 127–138. 10.1161/01.CIR.90.1.1278025988 van Werkhoven J. M. Gaemperli O. Schuijf J. D. Jukema J. W. Kroft L. J. Leschka S. . (2009b). Multislice computed tomography coronary angiography for risk stratification in patients with an intermediate pretest likelihood. Heart 95, 1607–1611. 10.1136/hrt.2009.16735319581272 van Werkhoven J. M. Schuijf J. D. Gaemperli O. Jukema J. W. Kroft L. J. Boersma E. . (2009a). Incremental prognostic value of multi-slice computed tomography coronary angiography over coronary artery calcium scoring in patients with suspected coronary artery disease. Eur. Heart J. 30, 2622–2629. 10.1093/eurheartj/ehp27219567382 Versteylen M. O. Kietselaer B. L. Dagnelie P. C. Joosen I. A. Dedic A. Raaijmakers R. H. . (2013). Additive value of semiautomated quantification of coronary artery disease using cardiac computed tomographic angiography to predict future acute coronary syndrome. J. Am. Coll. Cardiol. 61, 2296–2305. 10.1016/j.jacc.2013.02.06523562925 Vogel-Claussen J. Skrok J. Dombroski D. Shea S. M. Shapiro E. P. Bohlman M. . (2009). Comprehensive adenosine stress perfusion MRI defines the etiology of chest pain in the emergency room: Comparison with nuclear stress test. J. Magn. Reson. Imaging 30, 753–762. 10.1002/jmri.2189919787721 Voros S. (2009). What are the potential advantages and disadvantages of volumetric CT scanning? J. Cardiovasc. Comput. Tomogr. 3, 67–70. 10.1016/j.jcct.2008.12.01019201673 Voros S. Joshi P. Qian Z. Rinehart S. Vazquez-Figueroa J. G. Anderson H. . (2013). Apoprotein B small-dense LDL and impaired HDL remodeling is associated with larger plaque burden and more noncalcified plaque as assessed by coronary CT angiography and intravascular ultrasound with radiofrequency backscatter: results from the ATLANTA I study. J. Am. Heart Assoc. 2, e000344. 10.1161/JAHA.113.00034424252842 Voros S. Rinehart S. Qian Z. Joshi P. Vazquez G. Fischer C. . (2011). Coronary atherosclerosis imaging by coronary CT angiography: current status, correlation with intravascular interrogation and meta-analysis. JACC Cardiovasc. Imaging 4, 537–548. 10.1016/j.jcmg.2011.03.00621565743 Wagner A. Mahrholdt H. Holly T. A. Elliott M. D. Regenfus M. Parker M. . (2003). Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 361, 374–379. 10.1016/S0140-6736(03)12389-612573373 Walker S. Girardin F. McKenna C. Ball S. G. Nixon J. Plein S. . (2013). Cost-effectiveness of cardiovascular magnetic resonance in the diagnosis of coronary heart disease: an economic evaluation using data from the CE-MARC study. Heart 99, 873–881. 10.1136/heartjnl-2013-30362423591668 Weidemann F. Jamal F. Sutherland G. R. Claus P. Kowalski M. Hatle L. . (2002). Myocardial function defined by strain rate and strain during alterations in inotropic states and heart rate. Am. J. Physiol. Heart Circ. Physiol. 283, H792–H799. 10.1152/ajpheart.00025.200212124229 Yoo R. E. Park E. A. Lee W. Shim H. Kim Y. K. Chung J. W. . (2013). Image quality of adaptive iterative dose reduction 3D of coronary CT angiography of 640-slice CT: comparison with filtered back-projection. Int. J. Cardiovasc. Imaging 29, 669–676. 10.1007/s10554-012-0113-622923280 Youssef A. Ibrahim el S. H. Korosoglou G. Abraham M. R. Weiss R. G. Osman N. F. (2008). Strain-encoding cardiovascular magnetic resonance for assessment of right-ventricular regional function. J. Cardiovasc. Magn. Reson. 10, 33. 10.1186/1532-429X-10-3318601713 Zeb I. Abbas N. Nasir K. Budoff M. J. (2014). Coronary computed tomography as a cost-effective test strategy for coronary artery disease assessment - A systematic review. Atherosclerosis 234, 426–435. 10.1016/j.atherosclerosis.2014.02.01124769305 Zhang Y. X. Cliff W. J. Schoefl G. I. Higgins G. (1999). Coronary C-reactive protein distribution: its relation to development of atherosclerosis. Atherosclerosis 145, 375–379. 10.1016/S0021-9150(99)00105-710488966